Statins associated with better ICH outcomes

In this meta-analysis of patients with ICH, those who had been on a statin before the ICH had twice the odds of better functional outcomes, and half the odds of mortality at 90 days, compared to those not on a statin before the ICH. Although not a randomized trial, this study adds mounting evidence of a neuro-protective effect of statins (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment